Accelerating Innovation at Leica Biosystems

2012-2016 2017-2021E MOLECULAR DEVICES LSD HSD Accelerating Growth Across Life Sciences AVG. ANNUAL CORE GROWTH IMPROVEMENT HOW WE DO IT: Creating long-term value with DBS: increase margins, lower G&A, reinvest for growth "RUNNING THE DHR PLAYBOOK" BECKMAN COULTER Life Sciences LSD HSD/LDD SCIEX MSD MSD+ NEW PRODUCT LAUNCHES Applying DBS rigor to R&D processes to increase our cadence of innovation Leica LSD MSD STRATEGIC Enhancing capabilities and expanding MICROSYSTEMS ACQUISITIONS presence in attractive end-markets XXIDT INTEGRATED ONA. TECHNOLOGIES Acquired 2018 >20%* Combined Total: LSD MSD/HSD *2019-2021E Core Growth Enhancing growth trajectory with high-impact organic & inorganic investments DANAHER

View entire presentation